Stock IMRX IMMUNEERING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Immuneering Corporation

Equities

IMRX

US45254E1073

Market Closed - Nasdaq
Other stock markets
 02:00:01 04/05/2024 am IST 		5-day change 1st Jan Change
1.64 USD +5.13% Intraday chart for Immuneering Corporation +11.56% -77.69%
09/04 Immuneering Corporation Presents Preclinical Data At the American Association for Cancer Research Annual Meeting CI
02/04 Mizuho Adjusts Price Target on Immuneering to $8 From $20 on Revised Revenue Assumptions for Lead Asset IMM-1-104, Keeps Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. IMRX Stock
  4. Revisions Immuneering Corporation